MedPath

SANDOZ POSACONAZOLE

SANDOZ POSACONAZOLE

Approved
DIN Number

02496259

Drug Class

Human

Market Date

Dec 8, 2020

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02496259
AIG Number0152201002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC04 POSACONAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification08:14.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

POSACONAZOLEActive
Strength: 100 MG
Monograph: POSACONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.